Modulators Targeting Lipid Pathways
InquiryObesity and related metabolic disorders represent major global health challenges requiring targeted intervention strategies. Effective therapeutic development relies on high-quality chemical tools and bioactive compounds capable of precisely regulating biological networks that control lipid storage, mobilization, and oxidation. Protheragen provides an extensive catalog of validated modulators targeting lipid pathways, specifically engineered to accelerate weight loss therapy research and metabolic drug discovery.
Precision Lipid Modulation: Fueling Breakthroughs in Obesity Research
Lipid pathways control essential cellular functions including triacylglycerol synthesis, lipolysis in adipocytes, fatty acid uptake, and mitochondrial beta oxidation. By selectively acting on key regulatory enzymes, nuclear receptors, and lipid transport proteins, these modulator products allow researchers to manipulate cellular metabolic balances. Protheragen offers off-the-shelf compound libraries, purified enzyme inhibitors, receptor agonists, and specialized reference tools designed for high-throughput screening and functional bioanalysis.
Core Characteristics
Sphingolipid Dynamics & Atypical Metabolism
Sphingoid bases, ceramides, phytosphingosines, and 1-deoxy derivatives form a focused toolkit for atypical sphingolipid research, with isotope-labeled references enabling metabolic tracing and pathway resolution.
Oxysterols, Sterols & Bile Acid Intermediates
Oxygenated sterols, sulfated oxysterols, and isotope-labeled standards provide a broad chemical framework for cholesterol flux, LXR/SREBP signaling, and steroid metabolism studies.
Phosphoinositides, Cyclic LPAs & Signaling Lipids
Membrane lipid signaling can be dissected with cyclic LPA species, defined inositol phosphates, and functional phosphoinositide derivatives, covering receptor-linked events and intracellular messenger regulation.
Eicosanoids, Endocannabinoids & PAHSA Regulators
Metabolic inflammation, insulin responsiveness, and energy control can be explored through a diverse panel of prostaglandin-related compounds, endocannabinoids, and PAHSA-class lipid mediators.
Coenzyme A Esters, Acylcarnitines & Lipid A Formulations
A versatile set of CoA-linked and carnitine-conjugated fatty acids is complemented by structurally distinct Lipid A preparations, broadening the scope from lipid catabolism to innate immune signaling.
Targeted Small-Molecule Inhibitors & Receptor Ligands
Enzyme inhibition, receptor engagement, and metabolic pathway control are addressed through a purpose-built selection of pharmacological compounds and molecular modulators.
Applications
- Anti Obesity Therapeutic Discovery: Identification of novel chemical leads that enhance energy expenditure, stimulate fat burning, and reduce adipose tissue mass.
- Metabolic Syndrome Management: Exploration of small molecules designed to restore systemic lipid homeostasis and improve metabolic parameters in obese models.
- Nonalcoholic Fatty Liver Disease Research: Development of targeted agents that decrease hepatic lipid accumulation and prevent lipotoxic cellular damage.
- Type 2 Diabetes Pathway Exploration: Modulation of lipid signaling to improve peripheral insulin sensitivity and reduce excess circulating free fatty acids.
- Lipid Storage Disorder Studies: Research tools and reference standards for investigating genetic conditions characterized by abnormal lysosomal or cytosolic lipid storage.
Advantages
Rigorous Analytical Validation & High Purity
Every catalog compound is supported by complete analytical documentation, including nuclear magnetic resonance (NMR) spectra, mass spectrometry data, and high-performance liquid chromatography (HPLC) purity reports to ensure chemical identity, exceptional stability, and accurate quantitative dosing.
Broad Pathway Coverage & Target Diversity
Covers key metabolic targets across lipogenesis, nuclear receptor signaling, sphingolipid metabolism, and organelle dynamics, supporting diverse pathway investigations through one integrated research portfolio.
Flexible Packaging & Formulation Stability
Offered in customizable packaging formats and standardized, ready-to-use liquid formulations to streamline high-throughput screening workflows, accelerate assay setup, and maintain long-term compound stability.
Publication Data
Title: Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy
Journal: Journal of Pharmacy & Pharmaceutical Sciences, 2024
DOI: https://doi.org/10.3389/jpps.2024.12568
Summary: This narrative review investigates lipotoxicity as a key pathological mechanism and therapeutic target in obesity and diabetic cardiomyopathy, driven by excessive and abnormal lipid accumulation that surpasses cellular lipid droplet storage capacity and releases toxic lipid species. The authors synthesize recent mechanistic insights into lipotoxic cardiometabolic disease, highlighting how lipid overload triggers endoplasmic reticulum stress, mitochondrial dysfunction, chronic inflammation, and programmed cell death. By incorporating advanced omics and analytical findings, the review details key underlying drivers, including gut microbiota dysbiosis, epigenetic and epitranscriptomic modifications, lipid droplet dysfunction, aberrant post-translational modifications, and altered membrane lipid composition. Ultimately, this work clarifies the complex biochemical networks linking ectopic lipid accumulation to cardiac damage, emphasizing the clinical value of targeting lipotoxic pathways to mitigate heart failure and metabolic dysfunction in obesity and diabetes.
Fig. 1 Key mechanisms of lipotoxicity-driven cell and tissue damage. (Nakamura, 2024)
Customer Review
Reliable Screening Libraries for High-Throughput Assays
"Protheragen's lipid-focused compounds fit seamlessly into our screening workflow and simplified routine assay execution. Reliable lot-to-lot results have also helped us maintain greater confidence across successive screening runs."Dr. J. M., Senior Manager
Reproducible Dose-Response Profiles in Adipocyte Models
"The compounds performed consistently across primary cell assays without notable nonspecific toxicity. Clear product documentation and efficient technical assistance have further supported our day-to-day experimental work."Dr. H. L., Principal Scientist
Frequently Asked Questions
-
What compound purity levels are guaranteed for Protheragen lipid pathway modulators?
Our featured modulators undergo analytical testing to ensure chemical purities exceeding >95%, verified by mass spectrometry and liquid chromatography.
-
Can I order custom derivatives or structural analogs of catalog modulators for obesity research?
Yes. Our synthetic chemistry team produces custom structural analogs and isotopically labeled versions of any modulator in our portfolio upon request.
-
How can our scientific team obtain technical documentation or custom quotes?
You can request quotes, safety data sheets, and comprehensive analytical documentation by contacting our technical support team through our online inquiry portal.
Protheragen is a leading provider of high-quality modulators targeting lipid pathways for obesity research. By offering validated compound libraries, purified enzyme inhibitors, receptor ligands, and reference standards, we enable biopharmaceutical researchers to accelerate therapeutic discovery with absolute scientific confidence. Contact us today to discuss your experimental requirements and discover how our modulator products can advance your obesity research goals.
Reference
- Nakamura, M. Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy. Journal of Pharmacy & Pharmaceutical Sciences. 2024, 27: 12568. (CC BY 4.0)
Modulators Targeting Lipid Pathways
- Appearance: Solid
- Purity: ≥98%
- Identity: Confirmed by NMR and HPLC.
- Appearance: Solid
- Purity: ≥98%
- Identity: Confirmed by NMR and HPLC.
- Appearance: Liquid
- Purity: ≥95%
- Identity: Confirmed by IR, TLC, and HPLC.
- Appearance: Solid
- Purity: ≥98%
- Identity: Confirmed by NMR and HPLC.
- Appearance: Liquid
- Purity: ≥98%
- Identity: Confirmed by TLC and HPLC.
- Appearance: Crystalline solid
- Purity: ≥98%
- Identity: Confirmed by UV, TLC, and HPLC.
- Appearance: Liquid
- Purity: ≥98%
- Identity: Confirmed by IR and TLC.
- Appearance: Solid
- Purity: ≥98%
- Identity: Confirmed by NMR and HPLC.
- Appearance: Liquid
- Purity: ≥96%
- Identity: Confirmed by TLC and HPLC.
- Appearance: Solid
- Purity: ≥98%
- Identity: Confirmed by NMR and HPLC.